114 related articles for article (PubMed ID: 32986358)
1. The Effects of Combination of Mimic miR-155-5p and Antagonist miR-324-5p Encapsulated Chitosan in Ovarian Cancer SKOV3.
Suardi RB; Ysrafil Y; Sesotyosari SL; Martien R; Wardana T; Astuti I; Haryana SM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2603-2608. PubMed ID: 32986358
[TBL] [Abstract][Full Text] [Related]
2. The effects of miR-140-5p on the biological characteristics of ovarian cancer cells through the Wnt signaling pathway.
Wu Y; Li J; Chen S; Yu Z
Adv Clin Exp Med; 2020 Jul; 29(7):777-784. PubMed ID: 32750755
[TBL] [Abstract][Full Text] [Related]
3. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
4. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
5. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Shan W; Li J; Bai Y; Lu X
Tumour Biol; 2016 Apr; 37(4):5203-11. PubMed ID: 26553360
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
Liu CH; Jing XN; Liu XL; Qin SY; Liu MW; Hou CH
J Ovarian Res; 2020 Aug; 13(1):92. PubMed ID: 32782028
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.
Meng Q; Li Z; Pan J; Sun X
Hum Cell; 2020 Oct; 33(4):1240-1251. PubMed ID: 32749665
[TBL] [Abstract][Full Text] [Related]
8. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
9. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
Xu M; Zhou K; Wu Y; Wang L; Lu S
Mol Carcinog; 2019 Apr; 58(4):577-587. PubMed ID: 30556928
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression.
Ysrafil Y; Astuti I; Anwar SL; Martien R; Sumadi FAN; Wardhana T; Haryana SM
Adv Pharm Bull; 2020 Sep; 10(4):630-637. PubMed ID: 33062603
[No Abstract] [Full Text] [Related]
11. Circular RNA ITCH suppresses proliferation and promotes apoptosis in human epithelial ovarian cancer cells by sponging miR-10a-α.
Luo L; Gao YQ; Sun XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8119-8126. PubMed ID: 30556849
[TBL] [Abstract][Full Text] [Related]
12. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
13. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
17. Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids.
Vernon M; Lambert B; Meryet-Figuière M; Brotin E; Weiswald LB; Paysant H; Vigneron N; Wambecke A; Abeilard E; Giffard F; Louis MH; Blanc-Fournier C; Gauduchon P; Poulain L; Denoyelle C
Mol Cancer Ther; 2020 Jul; 19(7):1506-1519. PubMed ID: 32371581
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
[TBL] [Abstract][Full Text] [Related]
19. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
20. miR-485-5p improves the progression of ovarian cancer by targeting SRC in vitro and in vivo.
Yang Y; Liu J; Qian X; Li Y; Wang Y; Xu X
Neoplasma; 2020 Sep; 67(5):1022-1031. PubMed ID: 32538666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
